Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 15, 2021, titled "Glenmark launches Tiogiva��, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler".